| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.29 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |